Industry News

Kewaunee Scientific Corporation announced today its Board of Directors approved a fifteen percent increase in the quarterly cash dividend to fifteen cents per outstanding share from thirteen cents per outstanding share, payable on September 26, 2016 to stockholders of record at the close of business on September 12, 2016. We are confident the recent improvements in our financial results reflect sustainable operating..."/>
Kewaunee Scientific Corporation Raises Quarterly Dividend 15%
Pulmatrix, Inc. will present at the Rodman& Renshaw 18th Annual Global Investment Conference on Monday, September 12, 2016 at 5:30 PM EDT in the Lotte New York Palace Hotel in New York City. As part of the presentation, Robert W. Clarke, Ph.D., Chief Executive Officer for Pulmatrix, will provide an update on the Company's business and its pipeline of inhaled therapeutics. Among the highlights of the presentation will be positive data from a pilot..."/>
Pulmatrix to Present at the Rodman & Renshaw Global Investment Conference on September 12, 2016
Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, will visit the Nasdaq MarketSite in Times Square, to help kick off Ovarian Cancer Awareness Month. In honor of the occasion, Valerie Palmieri, President and Chief Executive Officer, will ring the Closing Bell along with OVA1 Blood Test Spokespersons:. Shannon Miller- America’ s Most Decorated Olympic Gymnast& Ovarian Cancer survivor Sherry Pollex- Life partner of NASCAR Driver Martin Truex, Jr. and..."/>
Vermillion, Inc. (Nasdaq: VRML) to Ring The Nasdaq Stock Market Closing Bell
Cigna and the Georgetown University National Center for Cultural Competence recently completed a successful pilot program that offered physicians the opportunity to take a Cultural and Linguistic Competence Health Practitioner Assessment. As a result of the pilot’ s success, the CLCHPA is now available online to all interested health care professionals on the NCCC’ s website,, with links from the Cigna Health Care Professional website."/>
Cigna, Georgetown University Help Physicians Meet Patients’ Cultural, Language Needs
Cross Country Healthcare, Inc., a Boca Raton-based leader in healthcare staffing and workforce solutions, announced today that its President and Chief Executive Officer, William J. Grubbs will be ringing the Nasdaq Stock Market Closing Bell today, Wednesday, August 31, 2016.. Grubbs for this exciting event will be several key members of Cross Country Healthcare’ s executive team. A national live streaming broadcast of Mr."/>
Cross Country Healthcare President and CEO, William J. Grubbs, will ring the Nasdaq Stock Market Closing Bell on Wednesday, August 31, 2016
Bio-Techne Corporation today announced that management will host its 2016 Investor Day on Thursday, September 15, 2016, starting at 9:00 a.m. EST. The meeting will take place at the Lotte New York Palace Hotel, 455 Madison Avenue, New York City. The Investor Day will feature presentations from members of Bio-Techne's senior leadership team followed by Q&A."/>
Bio-Techne Announces Investor Day And Webcast
IIROC Trading Halt - PM
SCYNEXIS, Inc. today announced that the Company will present at the following upcoming investor conferences:. The Baird Global Healthcare Conference at the New York Palace Hotel on Wednesday, September 7, 2016 at 4:20 p.m. ET. The 23 rd Annual NewsMakers in the Biotech Industry Investment Conference at the Millennium Broadway in New York on Friday, September 9, 2016 at 9:30 a.m. ET. The Aegis Growth Conference at the Wynn Las..."/>
SCYNEXIS, Inc. to Present at Upcoming Investor Conferences
Aeolus Pharmaceuticals, Inc., a biotechnology company developing compounds to protect against fibrosis, inflammation, nerve damage and infection, announced today that it will be presenting at the 2016 Aegis Growth Conference on Thursday, September 22nd at 9:00AM PDT/ 12 Noon EDT at the Encore at Wynn in Las Vegas. David C. Cavalier, Chairman and Chief Financial Officer will be giving the presentation and meeting with investors. Cavalier will provide an..."/>
Aeolus Pharmaceuticals to Present at Aegis Growth Conference on September 22, 2016
Array BioPharma Inc. today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Healthcare Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to..."/>
Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference
Cardinal Health Foundation to help fight prescription drug misuse by improving their communities' medication disposal programs. According to the 2013 National Survey on Drug Use and Health, nearly 70% of those who misuse prescription drugs get them from family members or friends, and often from the medicine cabinet. "One of the simplest and most effective ways to..."/>
Fighting Prescription Drug Misuse through Community Programs: Cardinal Health Foundation Announces Generation Rx Medication Disposal Grants
Streamline Health Solutions, Inc., provider of the Looking Glass ® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced that it will release its second quarter 2016 financial performance for the period that ended July 31, 2016, on Wednesday, September 7, 2016.. The Company will conduct a conference call to review the results on..."/>
Streamline Health® to Report Second Quarter 2016 Financial Performance on September 7, 2016
Calithera Biosciences, Inc., a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, today announced its participation at two upcoming healthcare investor conferences in September. The presentations will be webcast live, and available for replay for up to 30 days at in the..."/>
Calithera Biosciences to Present at Two Healthcare Conferences in September
Helius Medical Technologies, Inc. is pleased to announce HealthTech Connex Inc. in Surrey, British Columbia, will be the fourth site for the company's ongoing pivotal trial investigating PoNS™ Therapy for the treatment of subjects with balance disorder resulting from mild to moderate Traumatic Brain Injury. Clinical trial sites in the U.S. and Canada include the Montreal Neurofeedback Center, Oregon Health and..."/>
Helius Opens New Site for Pivotal Mild to Moderate Traumatic Brain Injury Trial at HealthTech Connex in Surrey, British Columbia
Aetna and Commonwealth Health are collaborating to establish a high-performance network that includes the introduction of a new health plan. The joint effort is aimed at improving the quality of patient care, creating new choices for consumers, and lowering overall health care costs. Commonwealth Health and Northeast Pennsylvania Quality Health Alliance, its clinically integrated physician network, will drive efforts to optimize efficiency, coordinate..."/>
Aetna and Commonwealth Health Create Product-Based High-Performance Network
Sensus Healthcare, Inc., a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that the Company will sponsor the First International Keloid Symposium to be held at The Rockefeller University in New York on Thursday, September 8 th and Friday, September 9 th.. The First International Keloid Symposium is a not for..."/>
Sensus Healthcare to Sponsor First International Keloid Symposium on September 8 and 9 in New York
OvaScience SM, a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that Harald Stock, Ph.D., President and Chief Executive Officer, will present a corporate overview at three upcoming conferences:. Live webcasts of the presentations can be accessed by visiting the Investors section of the Company’ s website at A replay of the webcasts will be archived on the..."/>
OvaScience to Present at Upcoming Investor Conferences in September
Exelixis, Inc. today announced that data from clinical trials of cabozantinib and cobimetinib will be the subject of 15 presentations at the European Society for Medical Oncology 2016 Congress in Copenhagen, October 7– 11, 2016.. Detailed results from CABOSUN, a randomized phase 2 clinical trial of cabozantinib compared with sunitinib in patients with previously..."/>
Exelixis-discovered Compounds To Be Featured in 15 Presentations at the ESMO 2016 Congress
Flexion Therapeutics, Inc. today announced that Michael Clayman, M.D., President and Chief Executive Officer, will provide a company overview at the 11 th Annual Wells Fargo Securities Healthcare Conference on Wednesday, September 7, 2016 at 2:55 p.m. EDT at the Westin Boston Waterfront.. To access the live webcast and subsequent archived recordings for the presentation, please visit the Flexion website at"/>
Flexion Therapeutics to Present at 2016 Wells Fargo Healthcare Conference
BioMarin to Attend Upcoming Investor Conferences
Histogenics Corporation, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced that Adam Gridley, President and Chief Executive Officer of Histogenics, will present at the 18 th Annual Rodman& Renshaw Global Investment Conference on Monday, September 12, 2016 at 11:40 AM EDT. The conference is sponsored by H.C. Wainwright& Co., LLC., and will be held September 11-13, 2016 at the..."/>
Histogenics Corporation to Present at the 18th Annual Rodman & Renshaw Global Investment Conference

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary579 Articles
Information Technology558 Articles
Financials432 Articles
Industrials343 Articles
Health Care319 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at